Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium-99m rhenium sulfide colloid
- Development stage
- Unknown
- Lead developer
- Curium
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Subcutaneous, Intradermal, Intravenous, Intraperitoneal, Oral
01
Overview
Technetium-99m rhenium sulfide colloid is a radiopharmaceutical, a colloid formulation of rhenium sulfide labeled with the gamma-emitting isotope technetium-99m (Tc-99m). It is primarily utilized as a diagnostic imaging agent for sentinel lymph node mapping (lymphoscintigraphy) in various cancers, including breast cancer and malignant melanoma. The colloid is designed to be taken up by the lymphatic system, allowing for the visualization of lymphatic drainage patterns. Beyond lymphatic imaging, it is also employed for imaging the reticuloendothelial system, encompassing the liver, spleen, and bone marrow, and for evaluating the patency of peritoneo-venous shunts. Furthermore, it can be used in studies of esophageal transit and gastroesophageal reflux. The diagnostic capability stems from the technetium-99m isotope's decay by isomeric transition, emitting detectable gamma photons.
- Brand names
- Nanocis
- Other names
- 99mTc-rhenium sulphide colloidtechnetium Tc 99m rhenium colloid
Beyond the preview
Go deeper on technetium-99m rhenium sulfide colloid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium-99m rhenium sulfide colloid.